Preparation, Crystal Structures and Hirshfeld Surface Analyses of Two Impurities of Azilsartan
Two impurities of azilsartan (1·EtOH and 2) have been prepared and the structures have been identified by 1H-NMR, IR and single crystal X-ray diffraction. Impurity 1·EtOH (C25H22N4O6, Mr = 474.46) crystallizes in triclinic, space group P-1 with a = 9.0425(15), b = 10.5498(18), c = 12.826(2) Å, α = 76.329(3), β = 79.086(3), γ = 76.763(3)°, V = 1145.4(3) Å3, Z = 2, F(000) = 496, Dc = 1.376 g/cm3, and µ = 0.100 mm− 1. Impurity 2 (C25H20N4O5, Mr = 456.45) is triclinic space group P-1 with a = 9.356(7), b = 9.490(8), c = 13.562(10) Å, α = 72.173(13), β = 73.864(12), γ = 82.628(15)°, V = 1099.9(15) Å3, Z = 2, F(000) = 476, Dc = 1.378 g/cm3, and µ = 0.098 mm−1. 1·EtOH shows a heteronuclear R 2 2 (8) dimeric structure through two N–H···O hydrogen bonds constructed by one 1,2,4-oxadiazol and one 2-oxo-benzimidazole groups, and ethanol molecule is attached by O–H···O hydrogen bond. Impurity 2 shows one-dimensional chain structure through two homonuclear R 2 2 (8) N–H···O hydrogen bonds constructed by two 1,2,4-oxadiazols and by two 2-oxo-benzimidazoles, respectively. Hirshfeld surface analysis shows that the hydrogen bonds are important to stabilize the conformation.
KeywordsAzilsartan Hirshfeld surface Impurity Crystal structure
We thank the Guangdong Provincial Department of Science and Technology (Grant Nos.: 2016A010121004 and 2016B090918075) for financial support of this research.
- 10.Rakugi H, Enya K (2012) Azilsartan: a new angiotensin II receptor blocker. Nihon Rinsho 70:1615–1620Google Scholar
- 11.Matsumoto S, Shimabukuro M, Fukuda D, Soeki T, Yamakawa K, Masuzaki H, Sata M (2014) Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser1177/Thr497 of endothelial nitric oxide synthase in diabetic mice. Cardiovasc Diabetol 13:30CrossRefGoogle Scholar
- 12.Gu WJ, Hou YT, Yang MH, Sun XM, Sui Q, Tang C (2014) HPLC determination of azilsartan content and its related substances. Chin J Pharm Anal 34:2185–2191Google Scholar
- 14.Sheldrick GM (1997) SHELXS-97, program for crystal structure refinement. University of Götingen, GötingenGoogle Scholar
- 15.Sheldrick GM (1997) SHELXS-97, program for crystal structure solution. University of Götingen, GötingenGoogle Scholar
- 17.Wolff SK, Grimwood DJ, McKinnon JJ, Jayatilaka D, Spackman MA (2015) CrystalExplorer 3.1. University of Western Australia, PerthGoogle Scholar
- 20.Spackman MA, Jayatilaka D (2009) Hirshfeld surface analysis CrystEngComm 11:19–32Google Scholar